Loading clinical trials...
Loading clinical trials...
Prospective Study of Quality of Life After Laparoscopic Removal of Essure®
A lot of patients seem to complain after hysteroscopic tubal occlusion by Essure® device with a worce quality of life. Investigators' hypothesis is that Essure® laparoscopic removal may improve quality of life. This prospectice study aim to assess the quality of life 1, 3, 6 and 12 months after Essure® removal.
Age
18 - No limit years
Sex
FEMALE
Healthy Volunteers
No
Gynaecology Department, Hôpital Femme Mère Enfant, Hospices Civils de Lyon
Bron, France
Start Date
October 14, 2017
Primary Completion Date
October 17, 2023
Completion Date
October 17, 2023
Last Updated
November 13, 2023
474
ACTUAL participants
Quality of life after Essure® removal
OTHER
Lead Sponsor
Hospices Civils de Lyon
NCT07444697
NCT06819592
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions